Man Group plc cut its holdings in Seer, Inc. (NASDAQ:SEER - Free Report) by 91.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,288 shares of the company's stock after selling 185,509 shares during the period. Man Group plc's holdings in Seer were worth $38,000 as of its most recent filing with the SEC.
Several other institutional investors also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its position in Seer by 67.5% in the third quarter. JPMorgan Chase & Co. now owns 175,354 shares of the company's stock valued at $345,000 after buying an additional 70,671 shares in the last quarter. D. E. Shaw & Co. Inc. boosted its stake in shares of Seer by 16.8% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 719,901 shares of the company's stock valued at $1,663,000 after purchasing an additional 103,630 shares during the last quarter. Peapod Lane Capital LLC bought a new position in Seer in the fourth quarter valued at approximately $991,000. Y Intercept Hong Kong Ltd acquired a new stake in shares of Seer during the fourth quarter worth $36,000. Finally, Corient Private Wealth LLC grew its position in shares of Seer by 66.0% during the 4th quarter. Corient Private Wealth LLC now owns 33,200 shares of the company's stock worth $77,000 after buying an additional 13,200 shares during the period. 75.20% of the stock is owned by institutional investors.
Seer Stock Performance
NASDAQ:SEER traded up $0.07 during trading hours on Friday, hitting $1.98. The stock had a trading volume of 326,637 shares, compared to its average volume of 342,553. Seer, Inc. has a one year low of $1.56 and a one year high of $2.63. The business's 50 day moving average is $1.94 and its 200-day moving average is $2.16. The company has a market cap of $116.27 million, a price-to-earnings ratio of -1.52 and a beta of 1.58.
Seer (NASDAQ:SEER - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.37) by $0.03. The business had revenue of $4.21 million during the quarter, compared to analysts' expectations of $3.25 million. Seer had a negative return on equity of 21.96% and a negative net margin of 565.83%. On average, sell-side analysts anticipate that Seer, Inc. will post -1.42 EPS for the current fiscal year.
Seer Company Profile
(
Free Report)
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Featured Articles
Before you consider Seer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.
While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
